Residential programs offer a daily routine that helps keep your focus on recovery. 24/7 Care and Support: Inpatient ...

From alcoholism to Parkinson’s, scientists are studying the mechanisms behind the broad clinical potential of weight-loss ...

Despite two-thirds of incarcerated people having substance use disorder, a new study reveals a lack of therapy options.

Opioid use disorder can be a contributing factor to Americans landing in the nation's prisons and jails, but those inmates ...

Patients on semaglutide, the active ingredient in Ozempic and the weight-loss drug Wegovy, were less than half as likely to overdose.

The new federal rules allow stable patients to take home 28 days’ worth of methadone. Colorado, New York and Massachusetts ...

Viewers of “Dopesick,” a 2021 TV miniseries drama about the damage wrought by opioid addiction, may recall that even the well ...

Adults with opioid use disorder who receive a higher daily dose of the opioid addiction treatment medication buprenorphine may have a lower risk of subsequent emergency department visits or use of ...

A study of people with type 2 diabetes and opioid use disorder suggests that the key ingredient in Ozempic and Wegovy shows promise against addiction.

A Denver man who struggled with an addiction to opioids and heroin for more than a decade is sharing his story of recovery in hopes of inspiring others.

The Earleville branch of the Recovery Centers of America at Bracebridge Hall recently introduced a new program for ...